InvestorsHub Logo
Followers 4
Posts 388
Boards Moderated 0
Alias Born 10/28/2013

Re: Jasbg post# 324436

Tuesday, 02/09/2021 6:46:01 PM

Tuesday, February 09, 2021 6:46:01 PM

Post# of 428589
Less about money. More about politics.

Teva was granted a rehearing. Which is a substantial risk and indicates generics get an easier ride.

I expect that whatever the outcome of the Amarin infringement suit expect it to go the same way thru the courts. Multiple appeals and generics always more likely to get appeals or rehearings.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News